Biochemistry of cancer

English
Strategic objectives
 
Early diagnosis of cancer and its treatment.
 
Main lines of research
 
1. Tumor markers: Abnormal Glycosylation of several proteins as potential tumor markers. Currently focused on prostate and pancreatic tumors, particularly in abnormal glycosylation of human pancreatic ribonuclease, acute phase proteins and PSA (prostate specific antigen). Extensible to other glycoproteins.
 
2. Molecular mechanisms responsible for changes in glycosylation in tumors:
· Expression studies of glycosyltransferases responsible for the biosynthesis of antigens associated to tumors
· Determination of their involvement in various stages of tumor progression and the factors that regulate their expression
 
3. Mechanisms of tumoral resistance.
· Molecular and cellular mechanisms determining the resistance of tumors to current therapies.
· Studies of the mechanisms of resistance to new agents for the emergence of ligand autocrine loop via the EGF / ErbB.
 
4. New anti-tumor agents.
· EGF analogues as anti-tumor agents. Antitumor effects of EGF truncated derivatives.
· Obtaining new derivatives as cytotoxic vehicles.
· Studies combined with other therapeutic agents such as those derived from metals: cisplatin, ruthenium and copper.
Early diagnosis of cancer and its treatment.
 
Group Leaders
 
Rafael de Llorens and Rosa Peracaula
 
Senior researchers
 
Rosa Nuria Aleixandre
 
Silvia Barrabés
 
Josep Comet
 
Mª José Ferri
 
Esther Llop
 
Mª Ángeles Martínez
 
Anna Massaguer
 
Medical researcher:
 
Manel Ramírez
 
Post-graduate researchers
 
Mertixell Balmaña
 
Montserrat Ferrer
 
Eva Plà
 

 

Geoposicio: 

Are you investigator?

English

If you research if you are interested in helping with any of our research groups, fill out this form. We will contact you as soon as possible. Thank you.

Send us your details

Read More